StockTipsArenaBeta

BUY BSE Ltd. — Rachna Vaidya

BUYBSE Ltd.
BSE share price target & all analyst calls

byRachna VaidyaHorizon: NA (inferred Swing (≤2wk))11 Nov 2026via CNBC Awaaz.

Entry₹3,890Inferred
Target₹3,950
Total upside +1.54% (call closed)
Stop lossNot given
Exit₹3,95012 Nov 2026, 9:25 am
Target hit+1.54%0.00%upside left
Follow Rachna Vaidya for new calls(47% target hit, 34 closed calls)Get alertsWatch BSE for new buy/sell callsGet alertsSee 4 active Swing calls on BSESee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Nov 2026
7 supporting4 neutral1 opposing
Supports the BUY call (7)

BSE Share Price Gains Over 2% After ICICI Securities Upgrades Rating To 'Add', Raises Target

NewsNdtv-Profit·11 Nov · today

(opens in new tab)

5 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·12 Nov · today

3 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·9 Nov · 2d ago

Strong GDP, policy support to drive India’s market growth: BSE CEO

NewsCnbc-Tv18·8 Nov · 3d ago

(opens in new tab)

BSE Q2 net profit rises 45% to ₹809 crore, revenue up 34%

NewsHbl·4 Nov · 1w ago

(opens in new tab)
Neutral / worth noting (4)

CAS weighs on NSE, BSE Q2 earnings; MCX rides gold, silver volatility

NewsLivemint·9 Nov · 2d ago

(opens in new tab)

BSE Q2 Review: Jefferies Maintains 'Underperform' Call, Raises Target Price

NewsNdtv-Profit·5 Nov · 1w ago

(opens in new tab)

BSE Share Price: What is the fair value that divided analysts see for the stock after Q2 results

NewsCnbc-Tv18·5 Nov · 1w ago

(opens in new tab)

Q2 Results Today Highlights: BSE, Apollo Hospitals, Sundaram Finance post higher profit in Q2; Biocon, Zydus Life profit declines

NewsHbl·4 Nov · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

BSE Q2 Results: Profit Dips Sequentially. A 24% Fall In Derivatives Premium Turnover To Be Blamed?

NewsNdtv-Profit·4 Nov · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on BSE

All analyst calls on BSE

More from Rachna Vaidya

Every call and its outcome